dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


Publication year:
All
51 - 60 out of 373Page size: 10
  1. 2022
  2. Published

    Migraine and light: A narrative review

    Artemenko, A. R., Filatova, E., Vorobyeva, Y. D., Do, T. P., dlt446, dlt446 & Danilov, A. B., 2022, In: Headache. 62, 1, p. 4-10 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences

    Ashina, H., Christensen, R. H. & dlt446, dlt446, 2022, In: Journal of Headache and Pain. 23, 1, 6 p., 87.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Assessment of Erenumab Safety and Efficacy in Patients with Migraine with and Without Aura: A Secondary Analysis of Randomized Clinical Trials

    dlt446, dlt446, Goadsby, P. J., Dodick, D. W., Tepper, S. J., Xue, F., Zhang, F., Brennan, F. & Paiva Da Silva Lima, G., Feb 2022, In: JAMA Neurology. 79, 2, p. 159-168 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

    dlt446, dlt446, McAllister, P., Cady, R., Hirman, J. & Ettrup, A., 2022, In: Cephalalgia. 42, 8, p. 696-704 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis

    dlt446, dlt446, Tepper, S. J., Brandes, J. L., Reuter, U., Boudreau, G. P., Weatherall, M., Gantenbein, A. R., Doležil, D., Klatt, J., Wang, A., Karanam, A. K., Cheng, S. & Mikol, D., 2022, In: Headache. 62, 5, p. 624-633 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

    dlt446, dlt446, Lanteri-Minet, M., Pozo-Rosich, P., Ettrup, A., Christoffersen, C. L., Josiassen, M. K., Phul, R. & Sperling, B., 2022, In: The Lancet Neurology. 21, 7, p. 597-607 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine

    dlt446, dlt446, 2022, In: Brain. 145, 8, p. 2619-2620 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  9. Published

    Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review

    Caronna, E., van den Hoek, T. C., Bolay, H., Garcia-Azorin, D., Gago-Veiga, A. B., Valeriani, M., Takizawa, T., Messlinger, K., Shapiro, R. E., Goadsby, P. J., dlt446, dlt446, Tassorelli, C., Diener, H. C., Terwindt, G. M. & Pozo-Rosich, P., 2022, In: Cephalalgia : an international journal of headache. 43, 1, p. 1-18 18 p.

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    Cluster headache – The worst possible pain on YouTube

    Chaudhry, B. A., Do, T. P., Ashina, H., dlt446, dlt446 & Amin, Faisal Mohammad, 2022, In: Headache. 62, 9, p. 1222-1226 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

    Christensen, C. E., dlt446, dlt446 & Amin, Faisal Mohammad, 2022, In: Pharmaceuticals. 15, 10, 11 p., 1189.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...38 Next

ID: 920785